RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
THE LANCET. ONCOLOGY
Collezione AOU Novara

Items : 5

Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. in The Lancet. Oncology / Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9.

2023
AOU Novara

Vitale A; Cabibbo G; Iavarone M; Viganò L; Pinato DJ; Ponziani FR; Lai Q; Casadei-Gardini A; Celsa C; Galati G; Gambato M; Crocetti L; Renzulli M; Giannini EG; Farinati F; Trevisani F; Cillo U;

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. in The Lancet. Oncology / Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8.

2023
AOU Novara

Zeng Q; Klein C; Caruso S; Maille P; Allende DS; Mínguez B; Iavarone M; Ningarhari M; Casadei-Gardini A; Pedica F; Rimini M; Perbellini R; Boulagnon-Rombi C; Heurgué A; Maggioni M; Rela M; Vij M; Baulande S; Legoix P; Lameiras S; Bruges L; Gnemmi V; Nault JC; Campani C; Rhee H; Park YN; Iñarrairaegui M; Garcia-Porrero G; Argemi J; et alii...

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry. in The Lancet. Oncology / Lancet Oncol. 2023 Apr;24(4):335-346. doi: 10.1016/S1470-2045(23)00056-6. Epub 2023 Mar 7.

2023
AOU Novara

Cortellini A; Tabernero J; Mukherjee U; Salazar R; Sureda A; Maluquer C; Ferrante D; Bower M; Sharkey R; Mirallas O; Plaja A; Cucurull M; Mesia R; Dalla Pria A; Newsom-Davis T; Van Hemelrijck M; Sita-Lumsden A; Apthorp E; Vincenzi B; Di Fazio GR; Tonini G; Pantano F; Bertuzzi A; Rossi S; Brunet J; Lambertini M; Pedrazzoli P; Biello F; D'Avanzo F; et alii...

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. in The Lancet. Oncology / Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.

2022
AOU Alessandria
AOU Novara

Prat A; Rimassa L; Aujayeb A; Queirolo P; Parisi A; Grosso F; Santoro A; Caliman E; Mazzoni F; Giusti R; Zambelli A; Martinez-Vila C; Cantini L; Patriarca A; Bruna R; Ruiz-Camps I; Gaidano G; Fox L; Roldán E; Doonga K; Saoudi-Gonzalez N; Perachino M; Rizzo G; García-Illescas D; Sharkey R; Carmona-García MC; Belessiotis K; Rogers L; Murphy C; et alii...

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Jun;15(7):730-7. doi: 10.1016/S1470-2045(14)70191-3. Epub 2014 May 13.

2014
AOU Città della Salute di Torino
AOU Novara

Zanni M; Gaudiano M; Congiu A; Castellino A; Dreyling M; Botto B; Zaccaria A; Fattori PP; Salvi F; Zinzani P; Molinari AL; Liberati AM; Ladetto M; Pavone V; Spina M; Inghirami G; Baldi I; Carella AM; Franceschetti S; Chiappella A; Vitolo U; Ciccone G; Gaidano G; Rossi G;